Catalyst Wire Dossier Catalyst Wire Dossier

ORGOVYX

RELUGOLIX · Sumitomo Pharma America, Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for ORGOVYX, covering 2020-12-18 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

See pricing